The University of Utah Clinical Genetics Research Program as an NF1 Consortium Site

reportActive / Technical Report | Accession Number: ADA465227 | Open PDF

Abstract:

The University of Utah Clinical Genetics Research Program CGRP provided the infrastructure for our site to perform clinical trials within the scope of a consortium to treat multiple medical complications of neurofibromatosis type 1. The U of Utah site executed aims of the overall consortium by attending 2 meetings of the consortium November, 2005 and April, 2006, participating in all teleconference calls, and active engagement in the development a The University of Utah Clinical Genetics Research Program CGRP provided the infrastructure for our site to perform clinical trials within the scope of a consortium to treat multiple medical complications of neurofibromatosis type 1. The U of Utah site executed aims of the overall consortium by attending 2 meetings of the consortium November, 2005 and April, 2006, participating in all teleconference calls, and active engagement in the development and submission of a clinical trials application to the Department of Defense in August, 2006. David Viskochil served as vice-chair of the Biology Committee, and he organized a symposium of investigators and clinicians who were part of a MPNST malignant peripheral nerve sheath tumor Consortium and the MPNST Committee of the NF1 Consortium that convened as a satellite meeting of the full NF1 Consortium meeting in Atlanta in April, 2006. A study coordinator has been hired through the CGRP at the U of Utah to assist in the development of material submitted in the clinical trials grant proposal. No data has been collected.

Author(s):
Viskochil, David H. ; Stevenson, David ; Carey, John
Author Organization(s):
UTAH UNIV SALT LAKE CITY
Descriptive Note:
Annual summary rept. 15 Oct 2005-1 Jan 2007
Supplementary Note:
The original document contains color images. DOI: 10.21236/ADA465227
Pagination:
0013

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release; Distribution Is Unlimited. This Document Is Not Available From Dtic In Microfiche.

RECORD

Collection: TR
Identifying Numbers
Contract/Grant Number(s):
W81XWH-06-1-0030
Monitor Series:
USAMRMC
 Subject Terms
Joint Capability Areas:
JCA_1.2.3_Educating; JCA_5_Command and Control
Modernization Areas:
Space
Communities of Interest:
Biomedical
Descriptor(s):
*GENETICS, *CLINICAL TRIALS, DEPARTMENT OF DEFENSE, SYMPOSIA, EPIDEMIOLOGY, SHEATHS(ANATOMY), NEOPLASMS, CONSORTIUMS
Field(s)/Group(s):
Medicine and Medical Research
Keyword(s):
*CLINICAL GENETICS RESEARCH PROGRAM, *NEUROFIBROMATOSIS TYPE 1, CGRP(CLINICAL GENETICS RESEARCH PROGRAM), MPNST(MALIGNANT PERIPHERAL NERVE SHEATH TUMOR), PROCEEDINGS, LEARNING PROBLEMS, MEDICAL COMPLICATIONS, DIAGNOSTIC IMAGING, SIGNAL TRANSDUCTION PATHWAYS, IMMUNOHISTOCHEMICAL PATTERNS, NF1 CONSORTIUM
Report Date:
2007 Feb 01
Creation Date:
2007 May 02